How to Choose a 5-MeO-DMT Facilitator: Safety Checklist

A Safety Checklist Before You Decide

1. UNDERSTAND THE LEGAL AND CLINICAL LIMITS

Under the current federal controlled substances schedule⁠, 5-MeO-DMT is a Schedule I controlled substance. Religious language, nonprofit status or a private training certificate does not by itself establish a legal exemption.

FDA approval applies to particular drug products and uses, not to a facilitator or retreat. Ask the provider to explain any legal or medical claims in writing. Consult an independent attorney for advice about your circumstances.

2. VERIFY THE PERSON’S ROLE AND CREDENTIALS

Ask exactly what role each person claims: facilitator, clergy member, coach, therapist, nurse, physician or another position. Request full names, training, current certifications and professional license numbers.

Verify California licenses through the Department of Consumer Affairs license search⁠ or the relevant professional board. A healthcare license does not automatically authorize every service, so ask whether the proposed activity falls within the person’s licensed scope.

Personal experience, testimonials, spiritual titles and years of practice do not independently establish medical competence or accountability.

3. REQUIRE PRIVATE, STRUCTURED SCREENING

Screening should occur privately and before payment or scheduling becomes difficult to reverse. It should address prescriptions, over-the-counter products, supplements, physical and psychiatric history, previous reactions, substance use, pregnancy where relevant and emergency contacts.

Ask who reviews this information, what conditions prompt postponement and when the provider refers someone to a licensed clinician. Screening reduces uncertainty but cannot guarantee safety.

A facilitator who is not your prescriber should not instruct you to stop, taper or change prescribed medication. Medication decisions belong with the prescribing clinician. Review 5-MeO-DMT Safety, Risks and Medication Interactions⁠ before making a decision.

4. EXPECT WRITTEN, INFORMED AND VOLUNTARY CONSENT

Written consent should describe the substance, uncertainty about benefits, possible risks, alternatives, fees, cancellation terms, confidentiality and what happens if you change your mind. It should acknowledge that someone may experience distress, receive no perceived benefit or develop symptoms that continue afterward.

Read the agreement while sober and without time pressure. You should receive understandable answers, retain a copy and remain free to withdraw before the experience without coercion.

The FDA’s informed-consent guidance⁠ applies to clinical research rather than retreats, but its principles provide a useful benchmark for understandable and voluntary consent.

5. DEFINE TOUCH AND PHYSICAL BOUNDARIES

Ask whether touch may be used, which forms may be proposed, why it might occur and how your preferences are recorded. Consent should be discussed while you are sober, remain specific and be revocable.

Sexual or intimate contact is unacceptable. Be cautious of blanket permission for restraint, undressing, painful practices, humiliation or expanded touch while you are impaired.

Health Canada’s psychedelic clinical-trial guidance⁠ calls for touch consent before drug administration and again in the moment, with contact remaining optional, non-intimate and nonsexual. This guidance is a clinical-trial benchmark, not certification of a private provider.

6. ASK ABOUT STAFFING AND CONTINUOUS SUPERVISION

Ask how many participants and sober staff will be present, who is directly responsible for you and whether staff members will have competing duties. Clarify whether you could ever be left alone and how privacy is protected when other participants are nearby.

Someone should remain responsible for observation until you are alert, oriented and able to transition safely. A large group, impressive venue or assistant with an undefined role does not establish adequate supervision.

Ask who makes decisions if the session lasts longer than expected or if additional help becomes necessary.

7. REVIEW THE EMERGENCY PLAN

Request a clear explanation of the written emergency plan. It should address how staff recognize a medical or psychiatric emergency, who contacts 911, how responders reach the location and how relevant health and substance information will be communicated.

Ask which staff members hold current first-aid or CPR credentials, who contacts your emergency person and what happens after emergency care is requested.

Remote locations, secrecy, reputation concerns or fear of attracting authorities should never delay emergency assistance. A statement that emergencies “never happen” is not an emergency plan.

8. ASK ABOUT THE SUBSTANCE AND SESSION PLAN

Ask what substance is represented, whether it is synthetic 5-MeO-DMT or animal-derived secretion, and how its identity, source and storage are documented. Appearance, smell, tradition or intuition does not prove identity or purity.

Animal-derived secretion can contain additional compounds and vary in composition. Collecting it also raises conservation and animal-welfare concerns. Synthetic material does not make an unregulated setting safe.

Ask whether repeat exposure may be proposed, what criteria are used and whether you can decline. More exposure should not be presented as proof of commitment or the default response to distress. This guide does not provide instructions for obtaining, testing, dosing or using controlled substances.

9. PLAN TRANSPORTATION AND RECOVERY

Agree on transportation before the session. Ask who determines readiness to leave, which observable criteria are used and what happens if recovery takes longer than expected.

Do not plan to drive or operate equipment while impaired. If the location is remote, confirm how a trusted support person or transportation provider will reach it. Ask whether appropriate lodging is available if leaving would be unsafe.

Oregon’s regulated psilocybin framework⁠ requires transportation and safety-support planning. Those rules concern psilocybin services in Oregon, not 5-MeO-DMT or California, but they demonstrate the value of making these plans in advance.

10. CONFIRM FOLLOW-UP AND CLINICAL REFERRALS

Preparation should include a sober discussion about expectations, consent, transportation, support and symptoms that require professional assessment.

Ask when follow-up occurs, how quickly the provider responds, who is available outside business hours and which licensed medical or mental health professionals accept referrals. The provider should be able to explain what happens if sleep, mood, perception or daily functioning worsens.

Another exposure should not be presented as the standard solution to a difficult reaction. Review 5-MeO-DMT Integration, Reactivations and Aftercare⁠ for grounded post-experience information.

11. REVIEW PRIVACY, FEES AND CONFLICTS

Obtain the complete price, deposits, refund rules, travel costs and required donations before agreeing. Ask whether the provider receives commissions from lodging, supplements, testing, therapy or referrals.

Permission for photographs, recordings, testimonials or data use should be separate and optional. Declining publicity should not affect the support you receive.

Ask what information is stored, who can access it, how long it is retained and how deletion is handled. Do not assume HIPAA applies to a retreat, coach or facilitator. Avoid arrangements without receipts, written terms or a way to report concerns.

12. RECOGNIZE THE RED FLAGS

Pause if you encounter:

• Same-day or superficial screening
• Pressure to decide, pay or participate quickly
• Guaranteed healing, cures or spiritual outcomes
• Claims that an experience is risk-free
• Advice to hide information from a clinician
• Instructions to stop medication without the prescriber
• Unclear substance identity
• Pressure for repeated exposure
• Sexualized, coercive or undefined touch
• Recording or testimonials without separate permission
• No written emergency or transportation plan
• Secrecy that could delay emergency care
• Resistance to outside medical or mental health support
• Vague credentials or unverifiable licenses
• Retaliation or shaming when someone asks questions

You may postpone, decline or leave without defending your decision. If answers are vague, inconsistent or hostile, do not proceed. Choosing not to participate remains a valid option.